Robert Uzzo
Urology · Philadelphia, PANPI 1841247194
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $84,499 of the $111,375 with a category attached, or 75.9%. 17 manufacturers reported payments, led by Merck at 31.8% of the total. Reporting peaked in 2021 at $31,787 and has fallen 56.2% since, to $13,933 in 2025. Among urology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $1310.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$35K
- Pfizer$34K
- Urogen Pharma, Inc.$18K
- Johnson & Johnson$11K
- Janssen Scientific Affairs, LLC$6K
- Immunitybio, Inc.$3K
- plus $5K from 11 others
Across 2 payments — averaging $2007.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$3K
- Novartis$1K
What the payments were for
- Consulting fees$84,49976%
- Speaking & faculty fees$23,84021%
- Travel & lodging$1,7292%
- Food & beverage$1,3071%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 25 | $35,397 |
| Pfizer | 15 | $34,318 |
| Urogen Pharma, Inc. | 12 | $18,041 |
| Johnson & Johnson | 12 | $10,752 |
| Janssen Scientific Affairs, LLC | 5 | $5,629 |
| Immunitybio, Inc. | 1 | $2,500 |
| Bayer | 1 | $2,296 |
| Amgen | 2 | $1,650 |
| Medtronic | 1 | $176 |
| Intuitive Surgical | 1 | $161 |
| Boston Scientific | 3 | $148 |
| Conmed Corporation | 1 | $119 |
| Daiichi Sankyo Inc. | 1 | $83 |
| Gilead | 1 | $38 |
| Roche Products Limited | 2 | $32 |
| Neotract Inc. | 1 | $27 |
| Ambu Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$111,375 in reported general payments places this provider in the 95th percentile of 596 urology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Philadelphia
- Demetrius BagleyPhiladelphia$739K
- Daniel EunPhiladelphia$226K
- Leonard GomellaPhiladelphia$190K
- Phillip GinsbergPhiladelphia$145K
- Edouard TrabulsiPhiladelphia$137K
- Siobhan HartiganPhiladelphia$121K
- Paul ChungPhiladelphia$120K
- William JaffePhiladelphia$119K
- Jay SimhanPhiladelphia$110K
- Trinity BivalacquaPhiladelphia$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.